People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

25 Nov 2020
Change (% chg)

$-0.12 (-2.93%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kiely, John 

Mr. John J. Kiely CPA serves as Independent Director of the Company. Mr. Kiely has more than 35 years of financial leadership and advisory experience serving public companies, including multi-national corporations. Until June 2019 he served as Senior Assurance Partner at Pricewaterhouse Coopers, where he focused on the pharmaceutical, manufacturing chemical and medical device sectors. From 1980 to June 2019, he held various roles of increasing responsibility at Pricewaterhouse Coopers, including as U.S. Pharmaceutical Leader and Global Pharmaceutical Assurance Leader. Mr. Kiely is currently and has been since July 2019 on the board of directors of Zovio, Inc., an education technology services company. Mr. Kiely holds a bachelor of science degree from Saint Francis University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 35,805
Long-Term Incentive Plans, USD --
All Other, USD 76,358
Fiscal Year Total, USD 112,163

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --